| 
             
			 It found that during 2014, 1.1 million people died of TB in 2014. 
			During the same period, HIV/AIDS killed 1.2 million people globally, 
			including 400,000 who were infected with both HIV and TB. 
			 
			Dr. Mario Raviglione, director of the WHO TB program, said the 
			report reflects the dramatic gains in access to HIV/AIDS treatment 
			in the past decade, which has helped many people survive their 
			infections. But it also reflects disparities in funding for the two 
			global killers. 
			 
			"The good news is that TB intervention has saved some 43 million 
			lives since 2000," but given that most cases of TB can be 
			successfully treated, the death rate remained "unacceptably high," 
			Raviglione said in a telephone interview. 
			  
			  
			 
			The report features data from 205 countries and territories on all 
			aspects of TB, including drug-resistant forms, research and 
			development and financing. 
			 
			It found that 6 million new cases of TB were reported to the WHO in 
			2014, fewer than two-thirds of the 9.6 million people worldwide 
			estimated to have fallen sick with TB last year. 
			 
			Among the estimated 480,000 cases of multi-drug resistant TB in 2014 
			- a superbug form of the disease that resists the two most potent 
			anti-TB drugs -, only one in four was diagnosed. 
			 
			Dr. Grania Brigden, interim medical director of Médecins Sans 
			Frontières, or Doctors Without Borders, said the report "should 
			serve as a wake-up call that enormous work still needs to be done to 
			reduce the burden of this ancient, yet curable disease." 
			 
			Funding disparities were a key issue, Raviglione said, noting that 
			international funding for HIV/AIDS is 10 times higher than for TB, 
			with $8 million spent on HIV/AIDS interventions, compared with a 
			total of $800,000 spent on TB. 
			
            [to top of second column]  | 
            
             
  
				
			 
			Part of that disparity is because HIV/AIDS largely affects 
			resource-poor countries in Africa, whereas TB is more prevalent in 
			countries such as India and China, which are better able to finance 
			their own domestic efforts to address TB infections. 
			 
			Even so, there remains a $1.4 billion gap in the amount of funding 
			needed for TB interventions in 2015. 
			 
			Raviglione said it is time to start funding TB at a level that can 
			make even more of a difference in curbing global deaths.(Corrects to 
			million 
			 
			(This story corrects billion to million in paragraph 9.) 
			 
			(Reporting by Julie Steenhuysen; Editing by Marguerita Choy) 
			[© 2015 Thomson Reuters. All rights 
				reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			 
			
			   |